IL153576A0 - Dna vaccines encoding hiv accessory proteins - Google Patents
Dna vaccines encoding hiv accessory proteinsInfo
- Publication number
- IL153576A0 IL153576A0 IL15357601A IL15357601A IL153576A0 IL 153576 A0 IL153576 A0 IL 153576A0 IL 15357601 A IL15357601 A IL 15357601A IL 15357601 A IL15357601 A IL 15357601A IL 153576 A0 IL153576 A0 IL 153576A0
- Authority
- IL
- Israel
- Prior art keywords
- dna vaccines
- accessory proteins
- encoding hiv
- vaccines encoding
- hiv accessory
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 230000001506 immunosuppresive effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
- C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
- C12Q1/703—Viruses associated with AIDS
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21819200P | 2000-07-14 | 2000-07-14 | |
| PCT/US2001/041357 WO2002006303A2 (en) | 2000-07-14 | 2001-07-12 | Dna vaccines encoding hiv accessory proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL153576A0 true IL153576A0 (en) | 2003-07-06 |
Family
ID=22814104
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15357601A IL153576A0 (en) | 2000-07-14 | 2001-07-12 | Dna vaccines encoding hiv accessory proteins |
| IL153576A IL153576A (en) | 2000-07-14 | 2002-12-22 | DNA vaccines that target HIV helper proteins |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL153576A IL153576A (en) | 2000-07-14 | 2002-12-22 | DNA vaccines that target HIV helper proteins |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7488484B2 (xx) |
| EP (1) | EP1301637B1 (xx) |
| JP (1) | JP2004525604A (xx) |
| KR (1) | KR100815888B1 (xx) |
| CN (1) | CN1312171C (xx) |
| AT (1) | ATE398188T1 (xx) |
| AU (2) | AU2001283493B2 (xx) |
| BR (1) | BR0112486A (xx) |
| CA (1) | CA2415187C (xx) |
| DE (1) | DE60134408D1 (xx) |
| DK (1) | DK1301637T3 (xx) |
| ES (1) | ES2307640T3 (xx) |
| IL (2) | IL153576A0 (xx) |
| PT (1) | PT1301637E (xx) |
| WO (1) | WO2002006303A2 (xx) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ536499A (en) | 2002-05-16 | 2008-04-30 | Bavarian Nordic As | Fusion protein comprising the amino acid sequence of at least four different HIV proteins selected from Vif, Vpr, Vpu, Vpx, Rev, Tat and Nef, wherein the fusion protein is not processed to individual HIV proteins having the natural N and C termini |
| TW200613554A (en) * | 2004-06-17 | 2006-05-01 | Wyeth Corp | Plasmid having three complete transcriptional units and immunogenic compositions for inducing an immune response to HIV |
| JP2009544333A (ja) | 2006-07-28 | 2009-12-17 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | 改良されたワクチンおよびそれを使用するための方法 |
| CN101897964B (zh) * | 2009-04-27 | 2013-04-10 | 中国农业大学 | 一种预防自身免疫疾病的药物 |
| SG178909A1 (en) * | 2009-10-08 | 2012-04-27 | Bavarian Nordic As | Generation of a broad t-cell response in humans against hiv |
| WO2015106003A1 (en) | 2014-01-08 | 2015-07-16 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Ras pathways as markers of protection against hiv and methods to improve vaccine efficacy |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5077044A (en) | 1980-05-19 | 1991-12-31 | The Board Of Trustees Of The Leland Stanford Jr. University | Novel non-reverting shigella live vaccines |
| US4873191A (en) | 1981-06-12 | 1989-10-10 | Ohio University | Genetic transformation of zygotes |
| US4722848A (en) | 1982-12-08 | 1988-02-02 | Health Research, Incorporated | Method for immunizing animals with synthetically modified vaccinia virus |
| US5110587A (en) | 1981-12-24 | 1992-05-05 | Health Research, Incorporated | Immunogenic composition comprising synthetically modified vaccinia virus |
| US5338683A (en) | 1981-12-24 | 1994-08-16 | Health Research Incorporated | Vaccinia virus containing DNA sequences encoding herpesvirus glycoproteins |
| US5174993A (en) | 1981-12-24 | 1992-12-29 | Health Research Inc. | Recombinant avipox virus and immunological use thereof |
| US4736866A (en) | 1984-06-22 | 1988-04-12 | President And Fellows Of Harvard College | Transgenic non-human mammals |
| JPS61170732A (ja) * | 1985-01-25 | 1986-08-01 | Fuji Photo Film Co Ltd | ハロゲン化銀写真感光材料 |
| GB8508845D0 (en) | 1985-04-04 | 1985-05-09 | Hoffmann La Roche | Vaccinia dna |
| US5223424A (en) | 1985-09-06 | 1993-06-29 | Prutech Research And Development | Attenuated herpesviruses and herpesviruses which include foreign DNA encoding an amino acid sequence |
| US5310668A (en) | 1986-06-20 | 1994-05-10 | Merck & Co., Inc. | Varicella-zoster virus as a live recombinant vaccine |
| US5242829A (en) | 1986-09-23 | 1993-09-07 | Therion Biologics Corporation | Recombinant pseudorabies virus |
| US5294441A (en) | 1987-06-04 | 1994-03-15 | Washington University | Avirulent microbes and uses therefor: salmonella typhi |
| US5387744A (en) | 1987-06-04 | 1995-02-07 | Washington University | Avirulent microbes and uses therefor: Salmonella typhi |
| IL86583A0 (en) | 1987-06-04 | 1988-11-15 | Molecular Eng Ass | Vaccine containing a derivative of a microbe and method for the production thereof |
| US5112749A (en) | 1987-10-02 | 1992-05-12 | Praxis Biologics, Inc. | Vaccines for the malaria circumsporozoite protein |
| US5225336A (en) | 1989-03-08 | 1993-07-06 | Health Research Incorporated | Recombinant poxvirus host range selection system |
| WO1990010693A1 (en) | 1989-03-08 | 1990-09-20 | Health Research, Inc. | Recombinant poxvirus host selection system |
| ES2090129T3 (es) | 1989-03-31 | 1996-10-16 | Univ Washington | Vacunas que contienen microorganismos tipo phop avirulentos. |
| EP0431668B1 (en) | 1989-12-04 | 1995-02-15 | Akzo Nobel N.V. | Recombinant herpesvirus of turkeys and live vector vaccines derived thereof |
| US5294548A (en) | 1990-04-02 | 1994-03-15 | American Biogenetic Sciences, Inc | Recombianant Hepatitis a virus |
| US5462734A (en) | 1990-11-02 | 1995-10-31 | Wisconsin Alumni Research Foundation | Bovine herpesvirus vaccine and method of using same |
| US5240703A (en) | 1991-03-01 | 1993-08-31 | Syntro Corporation | Attenuated, genetically-engineered pseudorabies virus s-prv-155 and uses thereof |
| US5593972A (en) | 1993-01-26 | 1997-01-14 | The Wistar Institute | Genetic immunization |
| US5482701A (en) * | 1993-05-03 | 1996-01-09 | Church & Dwight Co., Inc. | Microporous alkali metal bicarbonate |
| US5739118A (en) | 1994-04-01 | 1998-04-14 | Apollon, Inc. | Compositions and methods for delivery of genetic material |
| US5861161A (en) | 1994-09-07 | 1999-01-19 | Universite De Montreal | Chimeric proteins comprising a Vpr/Vpx virion incorporation domain for targeting into HIV-1 or HIV-2 virions |
| US5837533A (en) | 1994-09-28 | 1998-11-17 | American Home Products Corporation | Complexes comprising a nucleic acid bound to a cationic polyamine having an endosome disruption agent |
| JP2967094B2 (ja) * | 1995-11-02 | 1999-10-25 | 工業技術院長 | 窒化アルミニウム焼結体、及び窒化アルミニウム粉末の製造方法 |
| WO1999043839A1 (en) | 1998-02-27 | 1999-09-02 | The Trustees Of The University Of Pennsylvania | Vaccines, immunotherapeutics and methods for using the same |
| US7935805B1 (en) * | 1998-12-31 | 2011-05-03 | Novartis Vaccines & Diagnostics, Inc | Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof |
-
2001
- 2001-07-12 AT AT01962300T patent/ATE398188T1/de active
- 2001-07-12 DK DK01962300T patent/DK1301637T3/da active
- 2001-07-12 AU AU2001283493A patent/AU2001283493B2/en not_active Ceased
- 2001-07-12 CN CNB018127762A patent/CN1312171C/zh not_active Expired - Fee Related
- 2001-07-12 AU AU8349301A patent/AU8349301A/xx active Pending
- 2001-07-12 ES ES01962300T patent/ES2307640T3/es not_active Expired - Lifetime
- 2001-07-12 BR BR0112486-2A patent/BR0112486A/pt not_active IP Right Cessation
- 2001-07-12 IL IL15357601A patent/IL153576A0/xx unknown
- 2001-07-12 WO PCT/US2001/041357 patent/WO2002006303A2/en active Application Filing
- 2001-07-12 EP EP01962300A patent/EP1301637B1/en not_active Expired - Lifetime
- 2001-07-12 JP JP2002512204A patent/JP2004525604A/ja active Pending
- 2001-07-12 US US10/312,197 patent/US7488484B2/en not_active Expired - Lifetime
- 2001-07-12 PT PT01962300T patent/PT1301637E/pt unknown
- 2001-07-12 DE DE60134408T patent/DE60134408D1/de not_active Expired - Lifetime
- 2001-07-12 KR KR1020037000154A patent/KR100815888B1/ko not_active IP Right Cessation
- 2001-07-12 CA CA2415187A patent/CA2415187C/en not_active Expired - Fee Related
-
2002
- 2002-12-22 IL IL153576A patent/IL153576A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| BR0112486A (pt) | 2004-12-07 |
| ATE398188T1 (de) | 2008-07-15 |
| EP1301637B1 (en) | 2008-06-11 |
| CN1636013A (zh) | 2005-07-06 |
| EP1301637A2 (en) | 2003-04-16 |
| CA2415187A1 (en) | 2002-01-24 |
| KR20030016374A (ko) | 2003-02-26 |
| WO2002006303A3 (en) | 2002-08-15 |
| DK1301637T3 (da) | 2008-09-29 |
| CA2415187C (en) | 2013-06-18 |
| US7488484B2 (en) | 2009-02-10 |
| AU2001283493B2 (en) | 2006-11-30 |
| IL153576A (en) | 2010-11-30 |
| WO2002006303A2 (en) | 2002-01-24 |
| CN1312171C (zh) | 2007-04-25 |
| US20040106100A1 (en) | 2004-06-03 |
| DE60134408D1 (de) | 2008-07-24 |
| EP1301637A4 (en) | 2005-06-01 |
| AU8349301A (en) | 2002-01-30 |
| PT1301637E (pt) | 2008-09-18 |
| ES2307640T3 (es) | 2008-12-01 |
| KR100815888B1 (ko) | 2008-03-21 |
| JP2004525604A (ja) | 2004-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2002028867A3 (en) | Ethers of 7-desmethylrapamycin for use in immunosuppression | |
| YU9404A (sh) | Multimerna, usmerena kontrastna sredstva na bazi peptida | |
| WO2002028866A3 (en) | Hydroxyesters of 7-desmethylrapamycin | |
| BR0113975A (pt) | ésteres de rapamicina solúveis em água | |
| IL189629A0 (en) | Compositions containing human ctla-4 antibodies | |
| WO2002064096A3 (en) | Methods of using pyrimidine-based antiviral agents | |
| ATE319825T1 (de) | Verfahren und zusammensetzungen zur immunomodulation | |
| WO2003066661A3 (en) | Human dr4 antibodies and uses thereof | |
| AU2001235006A1 (en) | Prophylactic and therapeutic monoclonal antibodies | |
| DE60044247D1 (de) | Humane cd80-mutante und zusammensetzungen und methoden zu deren herstellung und verwendung | |
| WO2004031129A3 (en) | Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection | |
| WO2003010291A3 (en) | Treatment of immune disorders and b cell disorders | |
| IL153359A0 (en) | Peptides, compositions and methods for the treatment of burkholderia cepacia | |
| HK1054192B (zh) | Kahalalide f 的新配方 | |
| DE69911401D1 (en) | Immunoregulator | |
| AU2001269575A1 (en) | Nucleic acid sequences and proteins involved in cellular senescence | |
| WO2003092632A3 (en) | Cyclic peptide anti-cancer agents and methods | |
| IL153576A0 (en) | Dna vaccines encoding hiv accessory proteins | |
| HK1071079A1 (en) | Use of soluble fgl2 as an immunosuppressant | |
| WO2003102162A3 (en) | Novel tolerogenic dendritic cells and therapeutic uses therefor | |
| WO2002024867A3 (en) | Novel compositions and methods for lymphoma and leukemia | |
| EP1303300A4 (en) | COMPOSITIONS AND METHODS FOR TREATING CANDIDIASIS | |
| WO2002102324A3 (en) | Anti-arthropod vector vaccines methods of selecting and uses thereof | |
| WO2002077233A8 (en) | 38650, 28472, 5495, 65507, 81588 and 14354 METHODS AND COMPOSITIONS OF HUMAN PROTEINS AND USES THEREOF | |
| CY1108543T1 (el) | Εμβολια dna που κωδικοποιουν βοηθητικες πρωτεϊνες του hiv |